HIV-focused Gilead launches fund, pledges $2M to help transgender people

Studies show that transgender people in the U.S. are much more likely to be diagnosed with HIV than others. But with its latest funding effort, Gilead Sciences is looking to change that stat. It'll make an initial grant of $2 million to community groups across the U.S. that will help transgender people.